Jill Henrich - 03 Mar 2025 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
EVP, Chief Regulatory Officer
Signature
/s/ John Chao, Attorney-in-Fact for Jill Henrich
Issuer symbol
ATRA
Transactions as of
03 Mar 2025
Net transactions value
-$7,410
Form type
4
Filing time
05 Mar 2025, 17:16:33 UTC
Previous filing
20 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $7,410 -1,059 -5.4% $7.00 18,679 03 Mar 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 3, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F3 This amount includes 360 shares purchased under the Issuer's Employee Stock Purchase Plan on November 29, 2024.